Urologic Lymphadenectomy in AMIGO

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Brigham and Women's Hospital
Study ID
NCT05132283
Status
Recruiting
Apply to this trial

Conditions

  • Lymph Node Metastasis
  • Urologic Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • 3D Slicer — DEVICE
    Navigational device used during surgery to locate abnormal lymph nodes.
  • Monaco — DEVICE
    Navigational device used during surgery to locate abnormal lymph nodes.

Study Details

This research study involves the use of two navigation systems, the 3D Slicer-based navigation system, and the Siemens Monaco systems, to simplify the complexity of image-guided lymphadenectomy procedures (surgery to remove one or more lymph nodes) in patients with urological cancer.

Key Dates

First listed
Nov 24, 2021
Start date
Apr 1, 2022
Status verified
Jul 2026
Primary completion
Aug 1, 2026
Completion
Sep 1, 2026

Study Design

Enrollment
20 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: Urologic Lymphadenectomy in AMIGO
    Participants will undergo Lymphadenectomy per standard of care with the navigation systems (3D Slicer and Monaco) used to locate the abnormal lymph node(s).

Primary Outcome Measure

Proportion of Patients Completing Intended Procedure (Feasibility) [ Time Frame: One month, up to 45 days after registration ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Brigham and Women's HospitalBostonMassachusetts02115
Matthew Mossanen, MD
[email protected]
(617) 732-6384
Matthew Mossanen, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Boston, MA

By research site
Brigham and Women's Hospital· Boston, MA

Related Studies